Cargando…
Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering
Although the Plasmodium falciparum hexose transporter PfHT has emerged as a promising target for anti-malarial therapy, previously identified small-molecule inhibitors have lacked promising drug-like structural features necessary for development as clinical therapeutics. Taking advantage of emerging...
Autores principales: | Heitmeier, Monique R., Hresko, Richard C., Edwards, Rachel L., Prinsen, Michael J., Ilagan, Ma Xenia G., Odom John, Audrey R., Hruz, Paul W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508677/ https://www.ncbi.nlm.nih.gov/pubmed/31071153 http://dx.doi.org/10.1371/journal.pone.0216457 |
Ejemplares similares
-
Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds
por: Ortiz, Diana, et al.
Publicado: (2015) -
Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021) -
Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors
por: Owoloye, Afolabi J., et al.
Publicado: (2022) -
Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia
por: Heitmeier, Monique R., et al.
Publicado: (2018) -
An overview of the
Plasmodium falciparum
hexose transporter and its therapeutic interventions
por: Jiang, Xin
Publicado: (2022)